glp 1 and birth control GLP-1 medications are not approved by the Food Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label GLP 1 and Birth Control:

Patients with inflammatory bowel conditions, leaky gut, or NSAID-induced gastric damage have sought it as an adjunct or alternative therapy

The company provides strong support to its franchise partners through promotional materials, product guidance, and consistent supply

Firm, Painless Nodule A slowly enlarging, firm eyelid lump that is not painful often indicates a chalazion

Frequently asked questions Is tirzepatide levocarnitine FDA approved

We are confident and ready to meet demand so patients can count on timely access to Wegovy pill, explained Dave Moore, executive vice president of US Operations for Novo Nordisk Inc

It requires cofactors to function